Back to Search Start Over

Pattern and Rate of Cognitive Decline in Cerebral Small Vessel Disease: A Prospective Study

Authors :
Thomas R. Barrick
Robin G. Morris
Andrew J. Lawrence
Rebecca L. Brookes
Eva Zeestraten
Hugh S. Markus
Markus, Hugh [0000-0002-9794-5996]
Apollo - University of Cambridge Repository
Source :
PLoS ONE, Vol 10, Iss 8, p e0135523 (2015), Lawrence, A J, Brookes, R L, Zeestraten, E A, Barrick, T R, Morris, R G & Markus, H S 2015, ' Pattern and rate of cognitive decline in cerebral small vessel disease : a prospective study ', PLoS ONE, vol. 10, no. 8, e0135523, pp. 1-15 . https://doi.org/10.1371/journal.pone.0135523, PLoS ONE
Publication Year :
2015
Publisher :
Public Library of Science (PLoS), 2015.

Abstract

OBJECTIVES: Cognitive impairment, predominantly affecting processing speed and executive function, is an important consequence of cerebral small vessel disease (SVD). To date, few longitudinal studies of cognition in SVD have been conducted. We determined the pattern and rate of cognitive decline in SVD and used the results to determine sample size calculations for clinical trials of interventions reducing cognitive decline.METHODS: 121 patients with MRI confirmed lacunar stroke and leukoaraiosis were enrolled into the prospective St George's Cognition And Neuroimaging in Stroke (SCANS) study. Patients attended one baseline and three annual cognitive assessments providing 36 month follow-up data. Neuropsychological assessment comprised a battery of tests assessing working memory, long-term (episodic) memory, processing speed and executive function. We calculated annualized change in cognition for the 98 patients who completed at least two time-points.RESULTS: Task performance was heterogeneous, but significant cognitive decline was found for the executive function index (pCONCLUSIONS: The pattern of cognitive decline seen in SVD over three years is consistent with the pattern of impairments at baseline. Rates of decline were slow and sample sizes would need to be large for clinical trials aimed at halting decline beyond initial diagnosis using cognitive scores as an outcome measure. This emphasizes the importance of more sensitive surrogate markers in this disease.

Details

Language :
English
ISSN :
19326203
Volume :
10
Issue :
8
Database :
OpenAIRE
Journal :
PLoS ONE
Accession number :
edsair.doi.dedup.....1530005ab8aae6059d2b62d5c9b5cd96